Posts for Polyrizon Ltd. ($PLRZ)

Polyrizon Ltd. files Form 6-K reporting a new U.S. patent application for hydrogel nasal technologies, signaling growth potential and innovation. Signed by CEO Tomer Izraeli.

Polyrizon Ltd. reports the appointment of Dr. Michal Meir as Senior Director of Regulatory Affairs, signaling strategic growth. Key insights on leadership and compliance in the December 2024 report.